Next Article in Journal
Oral Maintenance Therapy in Early Breast Cancer—How Many Patients Are Potential Candidates?
Next Article in Special Issue
Salivary Microbiome Profiling of HPV+ and HPV− Oropharyngeal Head and Neck Cancer Patients Undergoing Durvalumab Immunotherapy Suggests Prevotella melaninogenica and Veillonella atypica as Key Players: A Pilot Study
Previous Article in Journal
Adjuvant Immunotherapy After Resected Melanoma: Survival Outcomes, Prognostic Factors and Patterns of Relapse
Previous Article in Special Issue
Emerging Radiotherapy Technologies for Head and Neck Squamous Cell Carcinoma: Challenges and Opportunities in the Era of Immunotherapy
 
 
Review

Article Versions Notes

Cancers 2025, 17(1), 144; https://doi.org/10.3390/cancers17010144
Action Date Notes Link
article xml file uploaded 5 January 2025 08:12 CET Original file -
article xml uploaded. 5 January 2025 08:12 CET Update https://www.mdpi.com/2072-6694/17/1/144/xml
article pdf uploaded. 5 January 2025 08:12 CET Version of Record https://www.mdpi.com/2072-6694/17/1/144/pdf
article html file updated 5 January 2025 08:13 CET Original file https://www.mdpi.com/2072-6694/17/1/144/html
Back to TopTop